Philip D. Gregory
62Patents
18h-index
44Co-inventors
84Inventor score
Filing activity: Aug 28, 2001 → Dec 18, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6933113B2 | Modulation of endogenous gene expression in cells | Chemistry; Metallurgy | 343 | Expired |
| US8586526B2 | DNA-binding proteins and uses thereof | Chemistry; Metallurgy | 192 | Active |
| US7220719B2 | Modulation of endogenous gene expression in cells | Chemistry; Metallurgy | 137 | Expired |
| US8956828B2 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Chemistry; Metallurgy | 128 | Active |
| US9597357B2 | T cell modifying compounds and uses thereof | Emerging Cross-Sectional Technologies | 93 | Active |
| US8110379B2 | Targeted integration into the PPP1R12C locus | Chemistry; Metallurgy | 86 | Active |
| US8945868B2 | Methods and compositions for modification of a HLA locus | Chemistry; Metallurgy | 76 | Active |
| US8563314B2 | Methods and compositions for modulating PD1 | Emerging Cross-Sectional Technologies | 53 | Active |
| US8071370B2 | Targeted modification of chromatin structure | Physics | 52 | Active |
| US9045763B2 | Linear donor constructs for targeted integration | Chemistry; Metallurgy | 50 | Active |
| US9255250B2 | Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene | Human Necessities | 39 | Active |
| US9458205B2 | Modified DNA-binding proteins and uses thereof | Chemistry; Metallurgy | 38 | Active |
| US9937207B2 | Targeted disruption of T cell receptor genes using talens | Chemistry; Metallurgy | 35 | Active |
| US8771985B2 | Genome editing of a Rosa locus using zinc-finger nucleases | Chemistry; Metallurgy | 34 | Active |
| US7358085B2 | Anti-angiogenic methods and compositions | Chemistry; Metallurgy | 26 | Expired |
| US7893022B2 | Anti-angiogenic methods and compositions | Chemistry; Metallurgy | 23 | Active |
| US8597912B2 | Methods and compositions for generation of Bax-and Bak-deficient cell lines | Chemistry; Metallurgy | 21 | Active |
| US8313925B2 | Zinc finger proteins and method for inactivating a dhfr gene in a chinese hamster ovary cell | Chemistry; Metallurgy | 19 | Active |
| US8012946B1 | Anti-angiogenic methods and compositions | Chemistry; Metallurgy | 15 | Active |
| US7785792B2 | Targeted modification of chromatin structure | Physics | 14 | Active |
| US7732196B2 | Anti-angiogenic methods and compositions | Chemistry; Metallurgy | 14 | Active |
| US8912138B2 | DNA-binding proteins and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US9234016B2 | Engineered zinc finger proteins for treating trinucleotide repeat disorders | Chemistry; Metallurgy | 12 | Active |
| US7795209B2 | Anti-angiogenic methods and compositions | Chemistry; Metallurgy | 12 | Active |
| US9175280B2 | Methods and compositions for treating hemophilia B | Human Necessities | 8 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.